Neoadjuvant chemotherapy with biwweekly docetaxel (D) and gemcitabine (G) in stage II and III breast cancer: a phase II clinical trial with pharmacogenomic study - Estevez, LG; Sanchez-Rovira, P; Domine, M; Leon, A; Jaen, A; Lozano, A; Casado, V; Rubio, G; Diaz-Miguel, M; Miro, C; Moreno-Bueno, G; Palacios, J; et al. (Breast Cancer Research And Treatment, 2003)